Table 1.
Factors | Number | IE (%) | Crude OR (95% CI) | Adjusted OR (95% CI) | P value (Wald's test) | P value (LR test) |
All | 7255 | 1125 (16) | ||||
Age (years) | <0.001 | |||||
0-14 | 36 | 4 (11) | 1.18 (0.41 to 3.34) | 0.97 (0.33 to 2.8) | 0.952 | |
15-64 | 3558 | 342 (10) | Reference | |||
65+ | 3661 | 779 (21) | 2.54 (2.22 to 2.91) | 2.42 (2.1 to 2.8) | <0.001 | |
Sex | 0.817 | |||||
Female | 2158 | 315 (15) | Reference | |||
Male | 5097 | 810 (16) | 1.11 (0.96 to 1.27) | 0.98 (0.85 to 1.14) | 0.817 | |
Area | <0.001 | |||||
Centre | 1332 | 234 (18) | Reference | |||
East | 419 | 76 (18) | 1.04 (0.78 to 1.38) | 1.12 (0.83 to 1.51) | 0.458 | |
Kaohsiung City | 1507 | 267 (18) | 1.01 (0.83 to 1.23) | 1.09 (0.89 to 1.33) | 0.419 | |
North | 740 | 98 (13) | 0.72 (0.55 to 0.92) | 0.77 (0.59 to 1) | 0.054 | |
South | 1087 | 179 (16) | 0.93 (0.75 to 1.15) | 0.95 (0.76 to 1.19) | 0.672 | |
Taipei City | 2170 | 271 (12) | 0.67 (0.55 to 0.81) | 0.75 (0.62 to 0.92) | 0.005 | |
Comorbidity | ||||||
CLD | 1192 | 277 (23) | 1.86 (1.6 to 2.17) | 1.91 (1.62 to 2.24) | <0.001 | <0.001 |
DM | 1191 | 136 (11) | 0.66 (0.55 to 0.8) | 0.64 (0.53 to 0.78) | <0.001 | <0.001 |
HIV | 30 | 4 (13) | 0.84 (0.29 to 2.4) | 1.52 (0.51 to 4.49) | 0.451 | 0.472 |
Initial level | <0.001 | |||||
A | 3104 | 539 (17) | Reference | |||
B | 1275 | 203 (16) | 0.9 (0.76 to 1.08) | 0.78 (0.65 to 0.93) | 0.007 | |
C | 1644 | 210 (13) | 0.7 (0.59 to 0.83) | 0.68 (0.57 to 0.82) | <0.001 | |
D | 1232 | 173 (14) | 0.78 (0.65 to 0.94) | 0.75 (0.62 to 0.92) | 0.005 | |
Pathway overlaps 2003 | 2110 | 493 (23) | 2.18 (1.91 to 2.48) | 2.32 (2.02 to 2.66) | <0.001 | <0.001 |
Healthcare facility levels: A, for primary care/ general practice; B, for regional hospitals with inpatient capacity; C, for larger district hospitals; D, for large hospitals with a range of specialists.
Comorbidities and pathway overlaps 2003 are binary variables, applying 'none' as the reference groups.
Crude and adjusted ORs were calculated from the results of univariate and multivariate logistic regressions, respectively.
CLD, chronic lung disease; DM, diabetes mellitus; IE, interrupted evaluation; LR, likelihood ratio.